0 items USD 0.00Search
Your search for "qyresearch china adalimumab industry report 2015" gave back 1507827 results.
Summary HeyReport estimates that the Adalimumab Biosimilar market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Adalimumab Biosimilar market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Behcet Disease Drug market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Behcet Disease Drug market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Polyarticular Juvenile Idiopathic Arthritis Drug market size will grow from xxx Million USD in 2020 to xxxx...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Summary Publisher estimates that the Polyarticular Juvenile Idiopathic Arthritis Drug market size will grow from xxx Million USD in 2020 to xxxx...
Catalog:
HYR
June 2021
Price: USD 2,000.00
The global Adalimumab Biosimilars market size is expected to reach $ 31050 million by 2029, rising at a market growth of 3.8% CAGR during the...
Catalog:
GIR
December 2023
Price: USD 4,480.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The global Adalimumab, Infliximab...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis,...
Catalog:
MRRPB5
April 2024
Price: USD 2,900.00
The global Adalimumab Biosimilars market size was valued at US$ 22690 million in 2022. With growing demand in downstream market, the Adalimumab...
Catalog:
LPI
December 2023
Price: USD 3,660.00
The global Adalimumab Biosimilars market size was valued at USD 23870 million in 2022 and is forecast to a readjusted size of USD 31050 million by...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Adalimumab Injection market size is expected to reach $ 2698.8 million by 2029, rising at a market growth of 5.4% CAGR during the forecast...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
